Moderna announced positive results for its Covid-19 vaccine in children aged 6 to 11 on Monday, October 25, data it plans to submit to regulators around the world "
in the short term
" for authorization.
Read also Covid-19: Moderna will set up a first vaccine plant in Africa
Clinical trials conducted on more than 4,700 children in this age group have shown a "
robust
"
immune response
in terms of antibody levels, and a "
favorable safety profile
," Moderna said in a statement.
